CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX)
CUSIP: 230770109
Q2 2019 13F Holders as of 30 Jun 2019
- Type / Class
- Equity / Common stock
- Shares outstanding
- 15,075,924
- Total 13F shares
- 4,768,946
- Share change
- -155,650
- Total reported value
- $30,376,000
- Price per share
- $6.37
- Number of holders
- 22
- Value change
- -$985,047
- Number of buys
- 9
- Number of sells
- 8
Quarterly Holders Quick Answers
What is CUSIP 230770109?
CUSIP 230770109 identifies CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 230770109:
Top shareholders of CPIX - CUMBERLAND PHARMACEUTICALS INC - Common stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Stonepine Capital Management, LLC |
13F
|
Company |
8%
|
1,201,975
|
$6,983,000 | — | 31 Mar 2019 | |
| ARIEL INVESTMENTS, LLC |
13F
|
Company |
8%
|
1,199,707
|
$6,970,000 | — | 31 Mar 2019 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
5.8%
|
876,239
|
$5,091,000 | — | 31 Mar 2019 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.6%
|
390,777
|
$2,270,000 | — | 31 Mar 2019 | |
| VANGUARD GROUP INC |
13F
|
Company |
2.4%
|
368,725
|
$2,142,000 | — | 31 Mar 2019 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.9%
|
283,790
|
$1,650,000 | — | 31 Mar 2019 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
200,400
|
$1,164,000 | — | 31 Mar 2019 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
0.65%
|
97,733
|
$566,000 | — | 31 Mar 2019 | |
| BARD ASSOCIATES INC |
13F
|
Company |
0.51%
|
77,115
|
$448,000 | — | 31 Mar 2019 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.36%
|
53,800
|
$313,000 | — | 31 Mar 2019 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.32%
|
48,610
|
$282,000 | — | 31 Mar 2019 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.17%
|
26,329
|
$153,000 | — | 31 Mar 2019 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
20,214
|
$118,000 | — | 31 Mar 2019 | |
| MORGAN STANLEY |
13F
|
Company |
0.13%
|
18,985
|
$110,000 | — | 31 Mar 2019 | |
| UNITED CAPITAL FINANCIAL ADVISORS, LLC |
13F
|
Company |
0.11%
|
16,604
|
$96,000 | — | 31 Mar 2019 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.09%
|
13,100
|
$76,000 | — | 31 Mar 2019 | |
| BlueCrest Capital Management Ltd |
13F
|
Company |
0.07%
|
10,906
|
$63,000 | — | 31 Mar 2019 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.07%
|
10,000
|
$58,000 | — | 31 Mar 2019 | |
| Russell Investments Group, Ltd. |
13F
|
Company |
0.03%
|
5,198
|
$31,000 | — | 31 Mar 2019 | |
| Oakworth Capital, Inc. |
13F
|
Company |
0.02%
|
3,052
|
$18,000 | — | 31 Mar 2019 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
1,000
|
$6,000 | — | 31 Mar 2019 | |
| SEI INVESTMENTS CO |
13F
|
Company |
0.01%
|
1,040
|
$2,000 | — | 31 Mar 2019 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
337
|
$2,000 | — | 31 Mar 2019 |
Institutional Holders of CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) as of Q2 2019
As of 30 Jun 2019,
CUMBERLAND PHARMACEUTICALS INC - Common stock (CPIX) was held by
22 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,768,946 shares.
The largest 10 holders included
ARIEL INVESTMENTS, LLC, Stonepine Capital Management, LLC, DIMENSIONAL FUND ADVISORS LP, RENAISSANCE TECHNOLOGIES LLC, VANGUARD GROUP INC, BlackRock Inc., BRIDGEWAY CAPITAL MANAGEMENT INC, ACADIAN ASSET MANAGEMENT LLC, BARD ASSOCIATES INC, and CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM.
This page lists
22
institutional shareholders reporting positions in this security
for the Q2 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2019 vs Q1 2019 Across Filers
Q1 2019 holders
22
Q2 2019 holders
22
Holder diff
0
| Investor | Q1 2019 Shares | Q2 2019 Shares | Share Diff | Share Chg % | Q1 2019 Value $ | Q2 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.